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Abstract: In a demanding commercial world, large-scale chemical processes have been widely
utilised to satisfy consumer related needs. Chemical industries are key to promoting economic
growth and meeting the requirements of a sustainable industrialised society. The market need
for diverse commodities produced by the chemical industry is rapidly expanding globally.
Accompanying this demand is an increased threat to the environment and to human health,
due to waste produced by increased industrial production. This increased demand has
underscored the necessity to increase reaction efficiencies, in order to reduce costs and increase
profits. The discovery of novel biocatalysts is a key method aimed at combating these
difficulties. Metagenomic technology, as a tool for uncovering novel biocatalysts, has great
potential and applicability and has already delivered many successful achievements. In this review
we discuss, recent developments and achievements in the field of biocatalysis. We highlight
how green chemistry principles through the application of biocatalysis, can be successfully
promoted and implemented in various industrial sectors. In addition, we demonstrate how two novel
lipases/esterases were mined from the marine environment by metagenomic analysis. Collectively
these improvements can result in increased efficiency, decreased energy consumption, reduced
waste and cost savings for the chemical industry.
Keywords: green chemistry; chemical industries; biocatalysis; metagenomics; marine; biodiscovery;
lipase; esterase
1. The Nature of the Modern Chemical Industry
Many chemical processes are time-consuming and have high associated costs. The atom
economy of many chemical processes is extremely inefficient, producing up to 100 times
more waste and by-products than the desired end product [1]. The Environmental Quotient
(EQ) was introduced to highlight this problem and provides a method of analysing reaction
efficiency and pollution [2]. Other important methods of reaction evaluation include the Reaction Mass
Efficiency (RME) and the Mass Intensity (MI) [3]. The Life-Cycle Assessment (LCA) is a comprehensive
approach to measure the environmental impact of a product. This technique measures the impact
from the sourcing of the raw material, through any processes involved in its production and usage,
as well as any disposal/recycling treatments [4]. Outlined in Table 1 are some of the most
important tools and techniques that green chemistry uses to measure environmental impact,
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effectiveness and efficiency of processes. In addition to processing issues, it is estimated that the
chemical industry is responsible for 25% of all of the industrial energy consumption in the U.S.
annually [5]. These inefficiencies, coupled with high energy consumption, place a significant financial
burden on the industry and need to be addressed.
Table 1. Definitions of concepts involved in green metrics.
Concept Abbreviation Definition
Atom Economy AE The amount of raw material used as a substrate that becomes a usefulproduct with the minimum waste production
Environmental
Quotient EQ
The relation between the mass of waste generated
during a process and the environmental impact that the waste causes
Reaction Mass
Efficiency RME
This concept takes into consideration not only the atom economy but
also the yield and stoichiometry of a chemical reaction
Mass Intensity MI The total mass of material, such as reactants, solvents, and reagents,used to produce a specific mass of product
The Life-Cycle
Assessment LCA
A technique to evaluate the environmental impact of the entire life
of a product, this included all the steps from the extraction of raw
material, manufacturing, storing, distribution, use,
disposal and recycling
In addition to challenges associated with reaction conditions and high input costs, the chemical
industries produce waste pollutants that can be costly to process and dispose of. Pollution comes
about through routine production processes and also through accidental contamination, both of which
can be expensive to resolve [6]. Environmental issues related to pollution are high on governmental
agendas and are being thoroughly investigated. These include, but are not limited to, air pollution,
water treatment, waste monitoring, waste minimization, and process improvement [7–10]. The majority
of the waste and by-products generated by chemical industries are known to be directly toxic to human
health [11]. Atmospheric pollution, is now considered the principal health risk to humans and has
recently been defined as a public health emergency [12]. Of the world’s population, 92% of people
are living with levels of air pollution exceeding the upper safety limits established by the World
Health Organisation (WHO) [13]. Total global premature deaths from airborne toxicants are estimated
to be in excess of 15 million people annually [14]. Furthermore, indirect effects of pollution can
also be detrimental as with aquatic and terrestrial pollutants. Hence, there is recognition for the
need to establish strong environmental regulations to assure enhanced wellbeing and a sustainable
future for the growing population that inhabits the Earth. For the chemical industry, overheads,
process inefficiencies, high costs, and pollution are issues that need to be addressed with haste. Green
chemistry provides an apt and apropos solution that can address many of these issues, as well as
proving significant added value to existing and new pipeline developments.
1.1. The Application and Benefits of Utilising Green Chemistry Solutions
Green chemistry is broadly defined as the application of 12 principles that lead to chemical
products and processes becoming more efficient, less toxic, and producing less waste [15]. These
principles can be divided into two broad groupings, (1) principles relating to reducing energy
utilisation and waste products and (2) principles relating to safer processes and products. Enzymes
have biocatalytic properties and have contributed greatly to the integration of green chemistry solutions
into the chemical industry [16].
The use of biocatalysts has been gaining strong momentum in the last number of years in an
attempt to deliver a more environmentally safe sustainable future [17–19]. The EU-COST Action D29
is a good example of frameworks set up to establish green chemical solutions. This initiative has
shown great success in applying green chemistry to solve a wide array of problems, from reducing
reaction temperatures to improving atom economy [20,21]. The chemical industry has also committed
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to producing more environmentally friendly solutions, where biocatalytic technologies are to the
fore [22]. There has been expansion in the application of enzyme biotechnology to the industrial sector.
This is mainly due to the environmentally friendly nature of enzymes, their ability to carry out reactions
more rapidly and efficiently than conventional processes and the associated reduction in production
costs [23,24]. There are now numerous examples of processes using biocatalysts that are vastly more
cost effective than their traditional counterparts [25–30]. We have outlined the benefits and diminishing
limitations of using green chemistry in Figure 1.
Both public and private sectors recognise the advantages in greener manufacturing and are,
therefore, heavily investing in projects such as “Chemical Manufacturing Methods for the 21st Century”
(CHEM21). This project is part of the EU Innovative Medicines Initiative (IMI) and aims to
support a transition towards more environmentally friendly drug manufacture. Six pharmaceutical
companies, thirteen European universities, and five small to medium enterprises are currently involved
in this initiative [22]. CHEM21 has noted that advancements in biocatalysis are made more feasible
with advancements in technologies such as bioinformatics and high-throughput screening. The global
economic enzyme market in 2016 was worth over $5 billion growing from $1.5 in 1998 [31,32]. It is
estimated that this figure will continue to grow and the industry will be valued in excess of $6.3 billion
by 2021 [33].
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successes, challenges remain. While academic research has gone some way towards elucidating the
metabolic parameters within which biocatalysts will need to operate in situ, often these do not translate
easily into large scale production systems [35]. Engineering of new chassis organisms for heterologous
biocatalytic conversions in small to medium scale reactors may not condition the cell for production in
industry-scale bioreactors. Furthermore, issues regarding stability of heterologous DNA, regulation
surrounding the use of genetically modified organisms, access to genetic resources as addressed by the
Nagoya protocol, and homogeneity of conditions within large scale bioreactors are key considerations
that must be met. The ultimate aim is a ‘one-pot’ solutions where several engineered strains combine to
deliver a product pipeline, will require intensive technological developments. We will need to further
our understanding of microbial-microbial interactions. Dynamic communication within microbial
communities is referred to as interactomics. In spite of interactomics challenges, the integration of
biocatalytic systems in industrial biotechnology has seen several successes.
The common enzymes that are applicable to industry are outlined in Figure 2. In the papermaking
process, lipases are replacing cleaning agents and talc which were used to avoid the forming
of pitch [36], the insoluble material produced during the mechanical processing of pulp [37].
This pitch can lead to a deterioration in the paper quality and also damage machinery used for
paper production. Since the introduction of lipases, this process has greatly reduced its energy
consumption and environmental impact [38]. Esterases are also used in recycled paper processing
replacing highly toxic solvents. These enzymes stop the agglomeration of glues by hydrolysing the
polyvinyl acetate, the main component of glues [39]. It is estimated that in the U.S., one billion
dollars are lost due to glue agglomeration [40]. Enzymes such as laccase and xylanase are used
to bleach paper, these substitute for harmful chlorine and alkali chemicals [41,42]. These enzymes
demonstrate practical fulfilment of the principles of green chemistry by increasing atom economy,
reducing cost and decreasing waste [38].
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Figure 2. The Growth and Application of the Enzyme Market. Listed are some of the enzyme categories
used by industry and the types of industries where the enzymes are widely employed. A PubMed
database was searched for the number of publications from 1998 to 2016 in relation to biocatalysis
using the following query: (biocatal*[Title/Abstract]). The total value of the enzyme market is also
included, from 1998 [32], to 2016 and the onward estimation up until 2021. The calculated trend-lines
clearly show an i crease in both market value and biocatalysts discovered.
Mar. Drugs 2018, 16, 227 5 of 21
Microplastics have been highlighted as a global pollutant. A recent review has detailed
eighty-three studies identifying microplastics in the marine environment [42]. While concentrations
varied, the microplastics were found distributed throughout the world. These microplastics affect
the fertility of marine organisms, such as oysters and copepods [43,44]. These particles can then be
transferred to humans via the food chain [44]. The plastic polyethylene (PE), is one of the largest
manufactured microplastics worldwide and one of the least recycled. Biocatalysis can be used to
metabolise this waste plastic to form useful value-added biopolymers [45]. Food and beverage
industries are responsible for major environmental issues [46] and with the population of the world
predicted to increase significantly the use of enzymes such as cellulases, pectinases, and amylases
which are used in clarification and maceration, will allow and facilitate the demand for efficient
food and beverage production. The use of these enzymes leads to cost reductions and improvement in
the quality of fruit juice [47]. In the bakery sector, amylases and lipases are used to increase softness,
flavour, and to prolong the shelf life of products [48]. During the production of cheeses, lipases are
often used to enhance the flavour and save on milk consumption [49].
Lipases, combined with other enzymes such as proteases, amylases and cellulases, play
an important role in the detergent industry. These enzymes are able to remove stains
without releasing toxic substances and can retain activity at low temperatures. The use of
these enzymes could eventually replace surfactants [50], which are extremely harmful for
aquatic environments [51]. Both amylases and proteases are successfully used in dishwasher
detergents to remove carbohydrates and proteins [52]. These enzymes can replace some of the
phosphates and bleaching agents that are highly harmful to the environment [53].
The pharmaceutical industry is also seeking alternatives to traditional chemical processes, in
order to create new greener processes with decreased hazardous waste and reduced costs. Therefore,
the application of biocatalysts has been gaining interest over time in the medical and pharmaceutical
industry [23,54]. An example of this is with the antidiabetic drug, Sitagliptin. This drug is
traditionally produced using high pressure in conjunction with expensive rhodium catalysts, however
biocatalytic technologies replaced this method and improved productivity by 53% as well as reducing
waste by 19% [55]. Another practical example is the use of the enzyme keto-reductase which is
involved in the production of the anti-asthmatic drug, Singulair. The use of this keto-reductase
produces a very pure (>99.9% ee; this is a measurement of the production of the desired
enantiomer) and high yields (>95%) of the drug. Moreover this enzyme replaces the hazardous
molecule (-)-B-chlorodiisopinocampheylborane which was used in the chemical production of the
drug [56]. Artemisinin, a sesquiterpene lactone, was originally isolated from the sweet wormwood
plant (Artemisia annua L.) [57]. It is used in the treatment of malaria, however, the sweet wormwood
plant is very rare and makes the production of the drug expensive [58]. In an effort to increase the
production of artemisinin, biocatalysis has been employed in the production of precursors of the
drug to decrease time and cost expenditures. A Saccharomyces cerevisiae strain was engineered by
chromosomal integration to produce high levels of the artemisinin precursor, artemisinic acid. Using
this engineered yeast in the production of artemisinin would be relatively easy, environmentally
friendly, and cost effective due to reduced contamination and solvents needed when compared the
plant extract techniques [59].
The discovery of new enzymes that conduct industrially important reactions is vital for
the industry’s future progression. The most successful and effective system for the discovery
of novel enzymes is with metagenomic technology. A hierarchical diagram, a Treemap,
representing defined publications was formed with nested rectangles corresponding to publication
abundance. The constructed Treemap (Figure 3) shows the biocatalysts that are industrially
relevant and discovered by metagenomic screens between the years 2014 to 2018. The Treemap
was created using a PubMed database search (accession on 4 April 2018 with the following query:
(metagenome*[Title/Abstract]) AND (X[Title/Abstract]) AND (‘2014/01/01’[Date—Publication]:
‘2018/04/04’[Date—Publication]) (X was substituted for each enzymatic class). Screens of metagenomic
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libraries of soil samples, have provided the most industrially important enzymes, followed by
animal and marine biomes/ecosystems. The most abundant enzymes discovered in the soil and animal
sources are cellulases, while lipases/esterases are the most abundant from the marine environment.
Lipases/esterases have previously been noted as having one of the most important impacts on chemical
processes and is applicable to a wide range of industries such as the food, detergent and pharmaceutical
industries [60].
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In the search for novel biocatalysts, the environment that the microorganisms inhabit
must be taken into consideration. The marine ecosystem occupies more than 70% of Earth’s
surface and offers a wide range of potential biocatalysts that have not previously been investigated.
Fossil records have demonstrated that marine bacterial life predated terrestrial bacteria by
600 million years [64]. Only 16% of defined living species are characterised from the marine
environment [65], and it is one of the least surveyed environments of any biome present on the planet,
with less than 0.0001% of the area of the deep oceans having been explored [66]. However the vast
majority of these microorganisms cannot be cultivated in the laboratory by current practices [67]. This
is due to many factors, including our inability to reproduce or mimic the nutrient and physicochemical
parameters needed to facilitate the growth of these microorganisms. This causes a bottleneck in enzyme
biodiscovery, which can now be addressed, in part, by the use of metagenomic tools.
The varied and extreme conditions of the marine biome, such as pH, low temperature, high
salinity, and high-pressure levels result in potentially industrially favourable enzymatic adaptations.
Extremophilic bacteria are microorganisms that have adapted to these harsh conditions. These bacteria
can produce extremozymes which are enzymes that catalyse reactions under atypical conditions [68].
These enzymes are a good example of enzymatic adaptations [69,70]. This makes these enzymes
important to chemical industries as often chemical processes need to be conducted under aberrant
conditions [71]. There are several examples of extremozymes with promising industrial value
(Table 2) [72–79].
Table 2. Important extremozymes and their industrially important properties.
Extremozyme Source Microorganism Property
Lipase
Waters of Baek-du
mountain Acinetobacter baumannii High activity at low temperatures [72]
China Yersinia enterocolitica Activity over a broad range of temperatures(0–60 ◦C) [73]
Saline soil from China Oceanobacillus rekensis 80% of activity at 10
◦C and fairly active in
the presence of long-chain alcohols [74]
Antarctica Bacillus pumilus 80% of their activity at 10 ◦C [75]
Intertidal flat of the
Yellow Sea in Korea
Photobacterium
lipolyticum Activity maintained at 5
◦C [76]
Protease
Indian ocean Marinobacter 60% activity is maintained at 80 ◦C [77]
Wastewater Bacillus licheniformis
Optimum temperature at
70 ◦C and stability towards
nonionic and anionic surfactants [78]
α-Amylase
Antarctic ice-shell Pseudoalteromonashaloplanktis
80% of enzyme activity at high NaCl
concentrations [79]
Wastewater Bacillus licheniformis
Optimum temperature at
90 ◦C and stability towards
nonionic and anionic surfactants [78]
Globally, it is estimated that 90% of the biosphere exists at temperatures below 10 ◦C [80,81].
There is great applicability for cold active enzymes from these environments to the food,
beverage and detergent market. Lipases from Bacillus pumilus were isolated from the
Antarctic and these enzymes maintained 80% of their activity at 10 ◦C, thus demonstrating
the potential industrial application for the food, organic synthesis and detergent industry [75].
Cold active alpha-amylases from Pseudoalteromonas haloplanktis have maintained 80% of its
activity at high salt concentration [79]. A cold-adapted lipase from Photobacterium lipolyticum
was discovered and maintained activity at 5 ◦C [76]. In contrast to cold active enzymes,
thermophilic enzymes have also been uncovered that have industrial importance, such as a protease
from a Marinobacter species, which retains 60% of their activity at 80 ◦C [77].
Sponges from the marine environment are of particular interest as resources for novel microbial
enzymes [82]. Marine sponges possess a large number of pores that circulate water and filter
nutrients and microorganisms. This develops a niche environment where microbial communities can
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grow and thrive [83]. Many microbes inhabit these niches within sponges, where often a symbiotic
mutualism may occur. The bacteria residing in the sponge, can be nearly half the biomass of the entire
sponge making them a rich resource of bacteria [84,85]. This rich resource of bacteria can be mined
for potential novel activities. Sponges have successfully been mined for their microbial biocatalyst
content with a wide range of enzymes being successfully discovered from a number of different sponge
sources [86–88]. The sponge Halichondria rugosa from South China Sea harboured a Bacillus pumilus
strain which had lipase activity [86]. From the sponge, Aplysina aerophoba, a novel esterase was
isolated from a marine Bacillus species [87]. Novel halotolerant lipases were found using metagenomic
libraries of the marine sponge, Haliclona simulans [88]. These successful applications further highlight
the potential unique and novel biocatalytic enzymes that could be mined from the marine biome,
especially from sponges.
Mining the Marine Biome for Novel Biocatalysts
The vast majority of microorganisms on the planet are unable to be grown routinely in the
laboratory which has been a major challenge when searching for new or novel biocatalysts. It is
estimated that 99% of bacteria cannot be cultured by traditional methods [89,90]. Hence, developing
optimised culturing conditions and media supplements to culture these organisms has been the
target of several research initiatives [91,92]. It is likely that a broad range of media will be required
to access the biodiversity that is currently unavailable to us [93]. Counterintuitively, often low
nutrient concentrations improve cultivation efficiencies [94,95]. Where culturability cannot be achieved,
applying metagenomics to uncover novel enzymes can circumvent these difficulties and hence increase
the chance of positive biocatalytic hits from complex samples [96].
For this reason, metagenomics has emerged as an important tool in the analysis of microbial
communities and for the detection of novel enzymes [97]. Prior to the construction of a metagenomic
library, the samples must be stored to maintain genomic (g)DNA integrity. To enhance the DNA
recovered, often filter and centrifugation methods are applied to capture as much of the DNA as
possible. Filtration was compared to centrifugation and was found to be the most efficient for isolation
purposes [98]. To access the gDNA from the sample, the cells must be lysed, while maintaining
the integrity of the gDNA. This is a very important step as this may alter the final results [99].
Techniques are available for the optimisation of gDNA quality, one method uses a modified chemical
extraction protocol and results in higher yields, lower shearing and increased lysis efficiency from
saline environments when compared to other chemical SDS-based techniques [100]. Other techniques
employ a combination of mechanical, chemical and enzymatic lysis to optimise the quality and quantity
of extractions from the marine environment. Methods using this combinatory approach were assessed
compared to a number of different techniques and was proven to be superior to these. This combination
technique was referred to as the THSTI method [101].
An important factor in the construction of a metagenomic library is the heterologous host used as
the chassis organism for expression studies. E. coli strains BL21 and K12 are the most common hosts for
the construction of metagenomic libraries [102]. Though they are the most common hosts for functional
analysis, not all proteins can be expressed in E. coli. Only 40% of enzymatic activity is expressed when
genes are randomly cloned into E. coli [103]. Due in part to difficulties in the recognition of foreign
promoters [104]. To address this issue, heterologous sigma factors have been introduced into E. coli to
improve expression [105]. There are several factors involved in the expression of a protein. A suitable
secretion system is required, with some E. coli strains having silenced secretion pathways [106]. Other
obstacles include the requirement for rare codons and codon usage bias, which together could make
expression of proteins problematic [107,108]. The formation of inclusion bodies is another issue faced
when trying to successfully produce an expressed protein in a heterologous system [109].
Utilising a selection of hosts which are genetically tractable, such as Pseudomonas, Streptomyces,
Bacillus, Agrobacterium and Rhodococcus, will increase the chance of expressing the metagenomic
library, thus increasing the likelihood of identifying enzymes of interest [110]. Often using hosts
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other than E. coli, such as hosts that are naturally present in the environment from which the sample
was collected, can increase the likelihood of the expression of the genes of interest. The expression
of a protein in the native form can be difficult when expressing it in E. coli. The expression of the
flavoprotein, hydroxylases 3-Hydroxybenzoate 6-Hydroxylase (3HB6H) from Rhodococcus jostii RHA1
is problematic as the expressed protein can be bound to two components of the cytoplasmic membrane
of E. coli, phosphatidylglycerol and phosphatidylethanolamine. The native expression is only bound
to phosphatidylinositol. R. jostii RHA1#2 was developed as an alternative host to produce the
native form of the protein [111]. This could also be seen when soil was screened for β-galactosidase
activity. Sinorhizobium meliloti was used as a host of the metagenomic library and β-galactosidase
activity was successfully identified [112]. A novel esterase was identified using the thermophile,
Thermus thermophilus as a host in a metagenomic library screen. This study noted that there
was a significant increase in the isolation of active clones when T. thermophilus was used as a host when
compared to E. coli as a host [113].
A metagenomics library can be constructed by using either small insert in plasmid vectors or
large inserts in fosmids or bacterial artificial chromosomes (BAC). Large insert fosmids and BAC
libraries can allow us to study complete metabolic pathways [114]. However small-insert libraries
are more useful for the isolation of activities encoded by a single gene or a quantitative study of
community composition [115,116]. The pCC1FOS fosmid vector (Epicentre) is commonly used when
constructing a metagenomic library with large insert sizes of 35–45 kb [117]. The pCC1FOS fosmid is
advantageous over other vectors for a number of reasons including the presence of a chloramphenicol
resistance marker gene within the vector, which is superior to other common markers such as ampicillin
when constructing libraries [118]. It is a broad-host-range fosmid, being maintained in diverse
members of Proteobacteria [119]. It is inducible for greater expression rates, with the supplementation
of L-arabinose in the media [120]. Recent studies have modified the pCC1FOS backbone to include
oriT, thus allowing the fosmid to be conjugated into a wide range of species. This modified fosmid is
now referred to as pRS44 [121,122].
When screening a metagenomic library, choosing the appropriate assay to detect new activities
is also important. For compounds other than hydrolases, there are few high throughput techniques
available for the screening of large metagenomic libraries. To detect enzymatic activity of
interest, a large number of clones often need to be screened. This makes the development of
high-throughput screening methods essential. Important developments in screening methods include
the ability for high-throughput screening of hydrolases [123–125]. An important industrial example
of a hydrolase is sulfatase [126]. One methodology utilises an ultraviolet (UV) light detection
system for the high throughput screening of sulfatases, this technology is based on the formation
of N-methylisoindole by sulfatases [127]. Another new high-throughput method uses colorimetric
assays for sulfatase activity [128]. The substrates that the enzymes are screened against are also
of great importance. To achieve high hit rates of enzymatic activities, multiple substrates should
be incorporated into a screen. This can increase the chances of identifying activity and may also
demonstrate activity specificity [129]. Screening multiple substrates for enzyme specificity is important
as it can identify new substrates that biocatalysts can convert to more value-added compounds.
This is demonstrated in a study whereby flavin-dependent enzymes, specifically vanillyl alcohol
oxidase and eugenol oxidase are used to catalyse the oxidation of para-substituted phenols [130].
Both these enzymes share sequence, secondary, and tertiary similarities, however they differ in
their substrate specificity [131,132]. Screening many substrates can be time consuming however
this group developed a high throughput colorimetric screening assay using xylenol orange to
rapidly screen twenty-four potential substrates for enzyme specificity. Utilising high-performance
thin-layer chromatography (HPTLC) is an example of a rapid method of screening and important
flavonoid-modifying enzymes have been identified using this technique [133]. Ultra-high-throughput
has emerged as being a promising technique due to its low cost and capacity to screen a large number
of clones. Ultra-high-throughput technologies differ to high-throughput methods as these techniques
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can often screen up to 10 billon potential activities per day. One example consists of a single clone
being encapsulated with a specific substrate into a droplet and the protein activity measured based on
absorbance or fluorescence [134,135].
Biosensors can also be used to detect enzymatic activity. A high-throughput GFP based
biosensor was used to identify biocatalysts for the transformation of lignin into commercially
important compounds [136]. While whole cell biosensors have been routinely applied in
environmental monitoring, their application in the drug synthesis pipeline is an emerging area
of technology development [137–139]. The ability to monitor substrate to product conversion in
situ within a production facility can streamline efficiencies within the pharmaceutical process.
Whole cell biosensors are typically comprised of two modules; the signal/analyte responsive
protein and the reporter module which produces a measurable output in the form of e.g., fluorescence
(gfp), luminescence (lux), or enzymatic activity (lacZ) [140]. As such, this represents a classic
modular system with significant potential for development using systems and synthetic biology
approaches. The sensory component of biosensors is generally a transcription factor, with LysR-type
transcriptional regulators (LTTR) having demonstrated considerable potential in this regard [141,142].
Notwithstanding their potential, limited understanding of the evolutionary drivers of LTTR
divergence, and the constraints on inter-domain coupling between heterologous LTTRs, has hampered
the development of hybrid ‘specific-purpose’ biosensors [143]. Other classes of biosensors have
already been successfully applied in monitoring the production of cis,cis-muconic acid [141].
Furthermore, a real-time highly sensitive microacoustic (Love Wave) device was used for the
detection of okadaic acid, specifically using HepG2 cell lines as the primary sensing elements [137].
Biosensors have also been used to screen for amidases from a metagenomics library, in this case
utilising a benzoate-responsive biosensor [144]. While many methods of detection rely on solid
media screens, a high-throughput liquid state assay has been developed to detect lipase activity from
metagenomics libraries [145]. This technique provides reproducibility and more accurate quantification
than its solid media based counterpart.
Apart from metagenomics analysis, the mining of genome sequences has been a useful tool
to discover new biocatalysts from a number of environments [146,147]. Currently there are
large volumes of genomic information in databases from marine sources and this is mostly due
to decreased sequencing cost and more efficient sequencing and annotation [148]. These DNA
sequences can be mined for potentially novel bioactives. Mining genome sequence techniques
have successfully been applied and have been used to identify fluorinases from Streptomyces,
Norcardia, and Actinoplanes species. These fluorinases have 80% to 87% sequence identity to a known
fluorinase from Streptomyces cattleya. The fluorinase from Streptomyces produces the fluorometabolites,
fluoroacetate and 4-fluo-rothreonine, similar to S. cattleya. However, it is also able to produce a variety
of unidentified fluorometabolites that could have industrial importance [149]. Bioinformatic
computational methods have been developed in order to characterize unknown proteins. Algorithms
investigate predictive active site as targets for computational programmes so that they can predict
the active sites of a proteins, thus inferring function [150,151]. To also achieve functional analysis,
sequenced-based methods use alignments and 3D structures to predict function [152]. Combinatory
techniques which combined the structure predictions and shapes of proteins with sequenced based
methodologies are some of the most useful [153]. Nevertheless, there is a large amount of genes
for which their function has yet to be described. This functional prediction difficulty is not only
limited to rare genes. Many genes that are required for the minimum function of life have yet to
be ascribed a purpose. However it has been predicted that many of these will be resolved in the
coming years, due to computational advancements [154]. Another recent study found that integrating
protein-protein interactions and protein domain information aided in the accuracy of predicting protein
function [155]. These protein models can all greatly aid in the discovery of novel biocatalysts from an
already existing database of sequences.
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3. Industrially Relevant Properties of Novel Marine Lipases/Esterases
Lipase and esterases catalyse the hydrolysis of ester bonds [156]. These enzymes are among the
most useful in industry. Therefore, identifying novel lipases and esterases from extreme environments,
such as the marine, could supply a variety of industries with more cost effective and environmental
friendly processes. Both lipase and esterase activities have been detected in the marine environment.
An example of a lipase with industrial importance was isolated from the marine fungus, Aspergillus
awamori [157]. This lipase could reduce up to 92% of fat in oil-laden effluent. A lipase from a marine
Janibacter species has important oil modification properties that are applicable in the food industry [158].
Moreover, it is important to note that this lipase is active at low temperatures, which would
be a beneficial property that is applicable to the food industry. The lipase, MAS1 from a marine
Streptomyces also fulfils green chemistry principles by performing an environmentally friendly
process, and moreover, uses a waste product, waste cooking oil, to produce commercially valuable
biodiesel [159].
Employing metagenomic strategies as a tool for discovery of novel biocatalysts provides the
ability to identify enzymes from unculturable organisms [160]. Numerous novel enzymes from
different environments have been discovered in the last number of years [61]. Marine lipolytic
enzymes can show unusual biochemical properties which are highly applicable to industrial processes.
Peng and colleagues screened a metagenomic library constructed from marine sediments [161]. They
discovered an alkaline-stable lipase which partially hydrolyses milkfat. This is highly valuable to
the dairy industry as it develops important organoleptic qualities, especially flavour. Important
alkali lipases have also been discovered from a metagenomic library from the marine sponge,
Iricina [162]. This lipase shows great potential to be utilised in the detergent industry, as well
as in organic synthesis processes due to its ability to tolerate organic solvents. Marine sponges
are a valuable resource for novel enzymes, however marine sediment has also been screened with
great success. A novel thermostable esterase was discovered from sediment with potential applications
in the biosynthesis of flavour esters [163]. Metagenomic libraries of samples from Polycyclic Aromatic
Hydrocarbon (PAH) and oil contaminated seawater have also been screened and five cold-adapted
esterases successfully identified [164]. These esterases are important as they show high activity at
low temperatures and were highly resistance to detergents, salts and solvents. A novel esterase,
which shows less than 27% sequence identity to the characterised lipolytic enzymes, was found
by screening a metagenomic library from samples from the South China Sea. This enzyme can be
particularly useful for industrial processes due to its high activity and ability to function at very high
salt concentrations [165]. While many important and useful enzymes have been found in the marine
environment, there is still a large reservoir of enzymes yet to be discovered.
4. Identification of Novel Enzymes from the Marine Environment by Metagenomic Analysis—A
Proof of Concept Case Study
To screen large quantities of enzymes of interest, metagenomic libraries coupled with screening
technologies is currently the method of choice. In order to construct a metagenomic library the first step
is to harvest the environmental sample and carry out the isolation of the DNA. To detect lipase/esterase
activity, a metagenomic library was screened. In our case study, sponge samples were collected from
Lough Hyne, a marine lake in the Southwest of Ireland. A metagenomics library (20,352 clones)
was constructed from the marine sponge Axinella dissimilis using one of the common hosts, E. coli
EPI300 and the fosmid vector pCCFOS1 [166]. The entire process that we applied in the case study is
outlined in Figure 4. Positive clones were detected by the appearance of a clear halo surrounding the
colony indicating the hydrolysis of tributyrin to glycerol and butyric acid [156]. To screen the large
library a QBIXS2-XT Microbial Colony Picker robot was employed to automate a rapid high throughput
screen. This screen is based on the ability of both lipase and esterase enzymes to metabolise tributyrin.
Further analysis is usually needed to distinguish the catalytic range of the positive clones. To induce
the fosmid from a single copy to a high copy number, 0.01% (w/v) L-arabinose was added to the media.
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This can increase the levels of expressed protein thus increasing the likelihood of detecting a positive
clone. From these lipase/esterase positive clones, the fosmid was extracted and digested by the
BamHI restriction enzyme. The digested fragments were sub-cloned into the expression vector,
pET28a(+) and conjugated into E. coli BL21 (DE3). The enzymes that were discovered were subsequently
characterised for specificity and speed of reaction [167,168]. Two interesting and novel lipase/esterases
were found by screening the marine sponge Axinella dissimilis metagenomic library. Each of these
hydrolases showed unique uncommon properties. The first hydrolase discovered has the ability
to hydrolyse a challenging substrate with a remote stereocenter and gives a very high yield of
specific products. The other hydrolase discovered in the metagenomics library showed an unusually
rapid reaction time with the target substrate metabolising tributyrin. These novel lipases/esterases
display a unique and promising activity. However, further improvements in the capabilities of
these enzymes could be accomplished by directed evolution strategies thus increasing their value for
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5. Advantages and Regulatory Compliance of Green Chemistry Solutions
Green chemistry offers many solutions to current pollution problems. It is also a field
rapidly increasing in market value. The use of enzymes in industrial processes can increase
production and lower hazardous outputs. Enzymes have replaced chemical processes in several
industries including the food, beverage, textile, detergent, and pharmaceutical industries. Biocatalysts
are becoming more profitable and replacing some traditional environmentally challenging processes
in industry. The use of enzymes is now becoming inevitable due to resource limitation and increasing
demands. Much work has been accomplished by the Environmental Protection Agency (EPA) and the
European Union, to monitor and evaluate the toxicity of commonly used chemicals, through the
Toxic Substances Control Act (TSCA) and Registration, Evaluation, Authorization and Restriction of
Chemicals (REACH) Act [170,171]. Through the application of more biocatalysts, much of the highly
toxic chemicals monitored and highlighted by these agencies will no longer be necessary. Applying
green chemistry solutions would allow for ease of compliance with the various plethora of regulations.
The marine environment is a relatively unexplored resource of enzymes. Industrial processes
need to be conducted under a wide range of conditions, many of these conditions are similar to
those found in the marine environment, such as in curing in the food industry. Since the majority
of microorganisms are not culturable routinely under laboratory conditions, investigating the needs
for the growth of these organism is pertinent, however heterologous expression often solves this
issue. Metagenomic strategies still currently offer one of the best opportunities to uncover new
bioactives. While utilising E. coli as the library host is still the most favoured, other hosts should
also be considered for expression analysis in particular those from the environment that the protein
is natively expressed in. High-throughput screening technologies of large metagenomic libraries
have increased the chances of the biodiscovery of biocatalysts. All of these methodologies lead to
more accurate and faster discovery of new types of enzymes. We have successfully demonstrated the
application of metagenomics to identify industrially important enzymes that adhere to green chemistry
principles. With the application of these enzymes and more biocatalysts to be discovered, the future of
the “Green Chemistry Landscape” looks very promising.
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